AU2002247725A1 - Antagonists fpr alpha4beta7-integrin - Google Patents

Antagonists fpr alpha4beta7-integrin

Info

Publication number
AU2002247725A1
AU2002247725A1 AU2002247725A AU2002247725A AU2002247725A1 AU 2002247725 A1 AU2002247725 A1 AU 2002247725A1 AU 2002247725 A AU2002247725 A AU 2002247725A AU 2002247725 A AU2002247725 A AU 2002247725A AU 2002247725 A1 AU2002247725 A1 AU 2002247725A1
Authority
AU
Australia
Prior art keywords
fpr
integrin
antagonists
antagonists fpr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002247725A
Other languages
English (en)
Inventor
Bernhard Holzmann
Horst Kessler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heidelberg Pharma AG
Original Assignee
Wilex AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wilex AG filed Critical Wilex AG
Publication of AU2002247725A1 publication Critical patent/AU2002247725A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002247725A 2001-02-19 2002-02-19 Antagonists fpr alpha4beta7-integrin Abandoned AU2002247725A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10107707.6 2001-02-19
DE2001107707 DE10107707A1 (de) 2001-02-19 2001-02-19 Antagonisten für alpha¶4¶beta¶7¶-Integrin
PCT/EP2002/001745 WO2002066500A2 (fr) 2001-02-19 2002-02-19 ANTAGONISTES DE Α4β7-INTEGRINE

Publications (1)

Publication Number Publication Date
AU2002247725A1 true AU2002247725A1 (en) 2002-09-04

Family

ID=7674566

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002247725A Abandoned AU2002247725A1 (en) 2001-02-19 2002-02-19 Antagonists fpr alpha4beta7-integrin

Country Status (3)

Country Link
AU (1) AU2002247725A1 (fr)
DE (1) DE10107707A1 (fr)
WO (1) WO2002066500A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011095218A1 (fr) * 2010-02-05 2011-08-11 Polyphor Ag Peptidomimétiques fixés au brin matrice ayant une activité modulatrice des cxcr7
US9273093B2 (en) 2012-10-11 2016-03-01 Protagonist Therapeutics, Inc. α4β7 peptide dimer antagonists
HRP20211911T1 (hr) 2013-03-15 2022-03-18 Protagonist Therapeutics, Inc. Analozi hepcidina i njihova uporaba
US20140294902A1 (en) * 2013-04-02 2014-10-02 Protagonist Therapeutics, Inc. Novel a4b7 peptide antagonists
PT3143037T (pt) 2014-05-16 2021-09-24 Protagonist Therapeutics Inc Antagonistas peptídicos tioéter de integrina alfa4beta7
SG10201810154WA (en) 2014-07-17 2018-12-28 Protagonist Therapeutics Inc Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
BR112017006826A2 (pt) 2014-10-01 2017-12-12 Protagonist Therapeutics Inc novos monômeros e dímeros peptídicos a4ss7 antagonistas
WO2016054445A1 (fr) 2014-10-01 2016-04-07 Protagonist Therapeutics, Inc. Nouveaux peptides monomères et dimères cycliques possédant une activité antagoniste de l'intégrine
US10787490B2 (en) 2015-07-15 2020-09-29 Protaganist Therapeutics, Inc. Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
US11046695B2 (en) * 2015-11-11 2021-06-29 Zealand Pharma A/S Fragment synthesis of substituted cyclic peptides
CA3009834A1 (fr) 2015-12-30 2017-07-06 Protagonist Therapeutics, Inc. Analogues de mimetiques d'hepcidine a demi-vie in vivo amelioree
CN115925790A (zh) 2016-03-23 2023-04-07 领导医疗有限公司 用于合成α4β7肽拮抗剂的方法
DK3538542T3 (da) 2016-11-11 2021-10-11 Zealand Pharma As Cykliske peptidmultimerer målrettet alfa-4beta-7-integrin
WO2018205008A1 (fr) 2017-05-10 2018-11-15 Encycle Therapeutics, Inc. PEPTIDES CYCLIQUES HOMODÉTIQUES CIBLANT L'INTÉGRINE α4β7
EP3681900A4 (fr) 2017-09-11 2021-09-08 Protagonist Therapeutics, Inc. Peptides d'agoniste opioïde et leurs utilisations
US11753443B2 (en) 2018-02-08 2023-09-12 Protagonist Therapeutics, Inc. Conjugated hepcidin mimetics
CN116082455A (zh) 2019-07-10 2023-05-09 领导医疗有限公司 白细胞介素-23受体的肽抑制剂及其用于治疗炎症性疾病的用途
EP4090670A1 (fr) 2020-01-15 2022-11-23 Janssen Biotech, Inc. Inhibiteurs peptidiques du récepteur de l'interleukine-23 et leur utilisation pour traiter des maladies inflammatoires
CN115279782A (zh) 2020-01-15 2022-11-01 詹森生物科技公司 白介素-23受体的肽抑制剂及其用于治疗炎性疾病的用途
KR20230110570A (ko) 2020-11-20 2023-07-24 얀센 파마슈티카 엔.브이. 인터류킨-23 수용체의 펩티드 억제제의 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037324A (en) * 1996-01-04 2000-03-14 Leukosite, Inc. Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor

Also Published As

Publication number Publication date
DE10107707A1 (de) 2002-08-29
WO2002066500A2 (fr) 2002-08-29
WO2002066500A3 (fr) 2003-01-30

Similar Documents

Publication Publication Date Title
AU2002341834A1 (en) Antagonists
AU2002360508A1 (en) Substituted hydroxyethylamines
AU2002313565A1 (en) Putter-heads
AU2002247725A1 (en) Antagonists fpr alpha4beta7-integrin
AU2002315122A1 (en) Self-guyed structures
AU2002251024A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
AU2003236247A1 (en) Bombesin antagonists
AU2002321215A1 (en) Substituted 4-aminocyclohexanols
AU2002346030A1 (en) Novel receptors
AU2002313943A1 (en) Electromobile
WO2002077001A9 (fr) Nouveaux recepteurs
AU2002226571A1 (en) Biligands
AU2001100406A4 (en) DriverSMS
AU2002360933A1 (en) Antagonists for alpha4-integrins
AU2002257925A1 (en) Numberplates
AU2001100522A4 (en) e-Trans
AU2002100746A4 (en) Adrail
AU2001100214A4 (en) Dolly-trolley
AU2001100532A4 (en) FonePark
AU2001100338A4 (en) Sunglove
AUPR910401A0 (en) Athesive additives
AU2002363642A1 (en) Nk1 antagonists
AU2002345578A1 (en) Construction
AU2002311774A1 (en) Novel receptors
AU2002358003A1 (en) Substituted acylaminophenyluracils

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase